Full Name
Katie Nolan-Stevaux
Job Title
Associate General Counsel, Litigation
Company
Genentech
Speaker Bio
Katie Nolan-Stevaux is an associate general counsel, litigation in global legal pharma at Genentech. Katie led world-wide biosimilar strategies for Rituxan/MabThera®, Actemra®, and Xolair® and defended the launch of Hemlibra®, a transformative hemophilia A medicine against Baxalta. She successfully led Genentech’s trade secret enforcement action against JHL Biotech and also coordinated with the government in the related criminal investigation. She is also a member of Roche’s Trade Secrets Council. Katie earned her JD at UC Berkeley, School of Law, a PhD in cell and developmental biology from Harvard University, and an undergraduate degree in biochemistry from Wellesley College.
Katie Nolan-Stevaux